Knockdown of RPN1-mediated aberrant protein hypoglycosylation can activate endoplasmic reticulum stress (ERS), thereby inhibiting the proliferation and invasion of breast cancer cells, promoting apoptosis, and suppressing tumor progression (8). Here, RPN1 is linked to breast cancer.